267 related articles for article (PubMed ID: 30304547)
1. Tamoxifen ameliorates obstructive nephropathy through Src and the PI3K/Akt/mTOR pathway.
Kim CS; Kim IJ; Choi JS; Bae EH; Ma SK; Kim SW
Biol Cell; 2019 Jan; 111(1):18-27. PubMed ID: 30304547
[TBL] [Abstract][Full Text] [Related]
2. Aloe-Emodin Ameliorates Renal Fibrosis Via Inhibiting PI3K/Akt/mTOR Signaling Pathway
Dou F; Liu Y; Liu L; Wang J; Sun T; Mu F; Guo Q; Guo C; Jia N; Liu W; Ding Y; Wen A
Rejuvenation Res; 2019 Jun; 22(3):218-229. PubMed ID: 30215298
[TBL] [Abstract][Full Text] [Related]
3. Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/mTOR and hedgehog signalling via increasing miR-193a expression.
Liu MW; Su MX; Tang DY; Hao L; Xun XH; Huang YQ
BMC Pulm Med; 2019 Feb; 19(1):35. PubMed ID: 30744607
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen ameliorates renal tubulointerstitial fibrosis by modulation of estrogen receptor α-mediated transforming growth factor-β1/Smad signaling pathway.
Kim D; Lee AS; Jung YJ; Yang KH; Lee S; Park SK; Kim W; Kang KP
Nephrol Dial Transplant; 2014 Nov; 29(11):2043-53. PubMed ID: 25031017
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptor-2 promotes kidney tubular epithelial inflammation by inhibiting autophagy via the PI3K/Akt/mTOR signalling pathway.
Du C; Zhang T; Xiao X; Shi Y; Duan H; Ren Y
Biochem J; 2017 Aug; 474(16):2733-2747. PubMed ID: 28694352
[TBL] [Abstract][Full Text] [Related]
6. Isoliquiritigenin inhibits TGF-β1-induced fibrogenesis through activating autophagy via PI3K/AKT/mTOR pathway in MRC-5 cells.
He J; Peng H; Wang M; Liu Y; Guo X; Wang B; Dai L; Cheng X; Meng Z; Yuan L; Cai F; Tang Y
Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):810-820. PubMed ID: 32638014
[TBL] [Abstract][Full Text] [Related]
7. Nrf2 signaling attenuates epithelial-to-mesenchymal transition and renal interstitial fibrosis via PI3K/Akt signaling pathways.
Wang J; Zhu H; Huang L; Zhu X; Sha J; Li G; Ma G; Zhang W; Gu M; Guo Y
Exp Mol Pathol; 2019 Dec; 111():104296. PubMed ID: 31449784
[TBL] [Abstract][Full Text] [Related]
8. Myo-Inositol Attenuates Renal Interstitial Fibrosis in Obstructive Nephropathy by Inhibiting PI3K/AKT Activation.
Hu X; Yang M; Li X; Gong Z; Duan J
J Med Food; 2023 Jun; 26(6):368-378. PubMed ID: 37192490
[TBL] [Abstract][Full Text] [Related]
9. A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques.
Jung KH; Ryu YL; Lee HS; Lee H; Son MK; Yan HH; Hong SW; Ryu JK; Hong S; Suh JK; Hong SS
Int J Oncol; 2013 Jun; 42(6):2001-8. PubMed ID: 23588860
[TBL] [Abstract][Full Text] [Related]
10. Fusaric acid (FA) protects heart failure induced by isoproterenol (ISP) in mice through fibrosis prevention via TGF-β1/SMADs and PI3K/AKT signaling pathways.
Li X; Zhang ZL; Wang HF
Biomed Pharmacother; 2017 Sep; 93():130-145. PubMed ID: 28624424
[TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
[TBL] [Abstract][Full Text] [Related]
12. BMP7-induced-Pten inhibits Akt and prevents renal fibrosis.
Higgins DF; Ewart LM; Masterson E; Tennant S; Grebnev G; Prunotto M; Pomposiello S; Conde-Knape K; Martin FM; Godson C
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3095-3104. PubMed ID: 28923783
[TBL] [Abstract][Full Text] [Related]
13. DNMT3a negatively regulates PTEN to activate the PI3K/AKT pathway to aggravate renal fibrosis.
Hu T; Chen F; Chen D; Liang H
Cell Signal; 2022 Aug; 96():110352. PubMed ID: 35523401
[TBL] [Abstract][Full Text] [Related]
14. Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis.
Yan Y; Ma L; Zhou X; Ponnusamy M; Tang J; Zhuang MA; Tolbert E; Bayliss G; Bai J; Zhuang S
Kidney Int; 2016 Jan; 89(1):68-81. PubMed ID: 26444028
[TBL] [Abstract][Full Text] [Related]
15. Tormentic acid inhibits hepatic stellate cells activation via blocking PI3K/Akt/mTOR and NF-κB signalling pathways.
Lin X; Li Y; Zhang X; Wei Y; Wen S; Lu Z; Huang Q; Wei J
Cell Biochem Funct; 2021 Jan; 39(1):77-87. PubMed ID: 32564421
[TBL] [Abstract][Full Text] [Related]
16. The fibrotic role of phosphatidylinositol-3-kinase/Akt pathway in injured skeletal muscle after acute contusion.
Li HY; Zhang QG; Chen JW; Chen SQ; Chen SY
Int J Sports Med; 2013 Sep; 34(9):789-94. PubMed ID: 23444088
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
18. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone promotes renal interstitial fibrosis via the AIF‑1/AKT/mTOR signaling pathway.
Yuan X; Wang X; Li Y; Li X; Zhang S; Hao L
Mol Med Rep; 2019 Nov; 20(5):4033-4044. PubMed ID: 31545432
[TBL] [Abstract][Full Text] [Related]
20. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K
Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
